ASCO 2021: Tecartus’ ZUMA-3 trial to support a first label in adult R/R ALL,

At this year’s virtual annual American Society of Clinical Oncology conference (ASCO 2021) on 4-8 June, results from the Phase II ZUMA-3 study for …, At this year’s virtual annual American Society of Clinical Oncology conference (ASCO 2021) on 4-8 June, results from the Phase II ZUMA-3 study for …, Read More

Scroll to Top